Teva Pharmaceuticals Usa Inc Supplemental Unemployment Benefit
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2018 | 28,570,632 | 28,569,707 | 925 | 0.0 | 0% |
| 2019 | 4,565,405 | 4,566,219 | −814 | 0.0 | 0% |
| 2020 | 21,048,540 | 21,047,615 | 925 | 0.0 | 0% |
| 2021 | 6,154,865 | 6,154,860 | 5 | 0.0 | 0% |
| 2022 | 4,787,474 | 4,785,647 | 1,827 | 0.0 | 0% |
| 2023 | 4,574,012 | 4,579,272 | −5,260 | 0.0 | 0% |
In its most recent public year (2023), this organization spent $5,260 more than it brought in. Its reserves stood at about 0 months of spending. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Teva Pharmaceuticals Usa Inc Supplemental Unemployment Benefit's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works